| Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations AR Padhani, G Liu, D Mu-Koh, TL Chenevert, HC Thoeny, T Takahara, ... Neoplasia 11 (2), 102-125, 2009 | 2406 | 2009 |
| Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2 B Turkbey, AB Rosenkrantz, MA Haider, AR Padhani, G Villeirs, ... European urology 76 (3), 340-351, 2019 | 2014 | 2019 |
| Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) MO Leach, CR Boggis, AK Dixon, DF Easton, RA Eeles, DG Evans, ... lancet 365 (9473), 1769-1778, 2005 | 1325 | 2005 |
| Imaging biomarker roadmap for cancer studies JPB O'connor, EO Aboagye, JE Adams, HJWL Aerts, SF Barrington, ... Nature reviews Clinical oncology 14 (3), 169-186, 2017 | 1111 | 2017 |
| Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting L Dickinson, HU Ahmed, C Allen, JO Barentsz, B Carey, JJ Futterer, ... European urology 59 (4), 477-494, 2011 | 898 | 2011 |
| Management of patients with advanced prostate cancer: the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017 S Gillessen, G Attard, TM Beer, H Beltran, A Bossi, R Bristow, B Carver, ... European urology 73 (2), 178-211, 2018 | 880* | 2018 |
| Head-to-head comparison of transrectal ultrasound-guided prostate biopsy versus multiparametric prostate resonance imaging with subsequent magnetic resonance-guided biopsy in … M van der Leest, E Cornel, B Israel, R Hendriks, AR Padhani, ... European urology 75 (4), 570-578, 2019 | 772 | 2019 |
| Synopsis of the PI-RADS v2 guidelines for multiparametric prostate magnetic resonance imaging and recommendations for use JO Barentsz, JC Weinreb, S Verma, HC Thoeny, CM Tempany, F Shtern, ... European urology 69 (1), 41, 2016 | 623 | 2016 |
| The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations MO Leach, KM Brindle, JL Evelhoch, JR Griffiths, MR Horsman, A Jackson, ... British journal of cancer 92 (9), 1599-1610, 2005 | 618 | 2005 |
| Dynamic contrast‐enhanced MRI in clinical oncology: current status and future directions AR Padhani Journal of Magnetic Resonance Imaging: An Official Journal of the …, 2002 | 598 | 2002 |
| Diffusion MRI for prediction of response of rectal cancer to chemoradiation A Dzik-Jurasz, C Domenig, M George, J Wolber, A Padhani, G Brown, ... The Lancet 360 (9329), 307-308, 2002 | 590 | 2002 |
| Technology insight: water diffusion MRI—a potential new biomarker of response to cancer therapy DM Patterson, AR Padhani, DJ Collins Nature clinical practice Oncology 5 (4), 220-233, 2008 | 464 | 2008 |
| Magnetic resonance imaging (MRI): considerations and applications in radiotherapy treatment planning VS Khoo, DP Dearnaley, DJ Finnigan, A Padhani, SF Tanner, MO Leach Radiotherapy and Oncology 42 (1), 1-15, 1997 | 461 | 1997 |
| Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA AR Padhani, CJ Gapinski, DA Macvicar, GJ Parker, J Suckling, PB Revell, ... Clinical radiology 55 (2), 99-109, 2000 | 457 | 2000 |
| Whole-body diffusion-weighted MR imaging in cancer: current status and research directions AR Padhani, DM Koh, DJ Collins Radiology 261 (3), 700-718, 2011 | 414 | 2011 |
| Reproducibility of dynamic contrast‐enhanced MRI in human muscle and tumours: comparison of quantitative and semi‐quantitative analysis SM Galbraith, MA Lodge, NJ Taylor, GJS Rustin, S Bentzen, JJ Stirling, ... NMR in Biomedicine: An International Journal Devoted to the Development and …, 2002 | 410 | 2002 |
| Imaging oxygenation of human tumours AR Padhani, KA Krohn, JS Lewis, M Alber European radiology 17, 861-872, 2007 | 396 | 2007 |
| The RECIST criteria: implications for diagnostic radiologists AR Padhani, L Ollivier The British journal of radiology 74 (887), 983-986, 2001 | 390 | 2001 |
| Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging SM Galbraith, RJ Maxwell, MA Lodge, GM Tozer, J Wilson, NJ Taylor, ... Journal of clinical oncology 21 (15), 2831-2842, 2003 | 389 | 2003 |
| Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015 S Gillessen, A Omlin, G Attard, JS De Bono, E Efstathiou, K Fizazi, ... Annals of Oncology 26 (8), 1589-1604, 2015 | 388 | 2015 |
David CollinsScientist Institute of Cancer ResearchVerified email at icr.ac.uk
